Access cutting-edge retinitis pigmentosa treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Access retinitis pigmentosa specialists in La Jolla at no cost
This study follows strict safety protocols and ethical guidelines
All study-related retinitis pigmentosa treatment provided free
This is a Phase 3 study to Assess the Efficacy, Safety and Tolerability of OCU400 in patients with retinitis pigmentosa (RP) associated with RHO mutations and patients with any other RP associated mutation with a clinical phenotype of RP. This is a multicenter, assessor blinded and randomized study which will enroll 150 subjects.
Sponsor: Ocugen
Check if you qualify for this retinitis pigmentosa clinical trial in La Jolla, CA
If you're searching for retinitis pigmentosa treatment options in La Jolla, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retinitis pigmentosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.